
Sign up to save your podcasts
Or


Venrock partner Bryan Roberts chats with Mathai Mammen about COVID-19 vaccine development and therapeutics in this special episode of Running Through Walls. Mammen serves as the Global Head of R&D at the Janssen Pharmaceutical Companies of Johnson & Johnson, where he is heading up the firm's COVID-19 vaccine development. They discuss J&J's unique approach to the vaccine and which therapeutics are promising in the fight against the virus. Mammen shares how the U.S. can be better prepared for the next pandemic, and highlights how his company approaches vaccine production and distribution on a global scale.
By Venrock, a venture capital firm4.8
6262 ratings
Venrock partner Bryan Roberts chats with Mathai Mammen about COVID-19 vaccine development and therapeutics in this special episode of Running Through Walls. Mammen serves as the Global Head of R&D at the Janssen Pharmaceutical Companies of Johnson & Johnson, where he is heading up the firm's COVID-19 vaccine development. They discuss J&J's unique approach to the vaccine and which therapeutics are promising in the fight against the virus. Mammen shares how the U.S. can be better prepared for the next pandemic, and highlights how his company approaches vaccine production and distribution on a global scale.

1,289 Listeners

2,672 Listeners

2,444 Listeners

1,100 Listeners

341 Listeners

324 Listeners

394 Listeners

5,526 Listeners

9,901 Listeners

34 Listeners

505 Listeners

19 Listeners

263 Listeners

517 Listeners

1,354 Listeners